Metabolomic Characteristics of Patients With Non-small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-control Study
Completed
74 enrolled
Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
Completed
9,759 enrolled
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
Completed
296 enrolled
Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Completed
240 enrolled
KELSO
Completed
1,200 enrolled
Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy
Completed
273 enrolled
Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer
Completed
41 enrolled
Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer
Completed
182 enrolled
TraveraRTGx
Completed
72 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
Completed
102 enrolled
Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
Completed
60 enrolled
3D-LUNG
Completed
13 enrolled
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
Completed
24 enrolled
LBM-T790M
Completed
70 enrolled
Lung Cancer Risk Assessment and Etiology
Completed
109 enrolled
ALTAK
Completed
385 enrolled
CB(NPC)²
Completed
518 enrolled
PMCF Study of the CE-marked Drainova® ArgentiC Catheter
Completed
169 enrolled
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Completed
73 enrolled 12 charts
UNCOVER
Completed
833 enrolled
Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
Completed
46 enrolled
From Presentation to Diagnosis: Patterns of Pleural Effusion
Completed
300 enrolled
SCLC
Completed
272 enrolled
SARCO-CTI
Completed
131 enrolled
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Completed
500 enrolled
Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)
Completed
45 enrolled
Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Completed
188 enrolled
SOLID
Completed
1,980 enrolled
A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients
Completed
100 enrolled
LUDICAS
Completed
553 enrolled 6 charts
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Completed
64 enrolled
Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases
Completed
4,864 enrolled
Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
Completed
350 enrolled
Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas
Completed
21,692 enrolled
Mobilization Before and After Video-Assisted Thoracoscopic Surgery Lobectomy/Segmentectomy
Completed
51 enrolled
Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients
Completed
196 enrolled
A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
Completed
70 enrolled
CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
Completed
33 enrolled
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Completed
135 enrolled
PRINCE
Completed
106 enrolled
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
Completed
49 enrolled
IMPLICATION
Completed
167 enrolled
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
Completed
100 enrolled
Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
Completed
2,072 enrolled
LIST
Completed
535 enrolled
LUCENCE
Completed
212 enrolled
AID-CXR
Completed
33 enrolled
Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy
Completed
3,000 enrolled
Imfinzi PMS
Completed
712 enrolled